We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bacterium Induced to Resist Radiation Damage in the Lab

By LabMedica International staff writers
Posted on 30 Mar 2014
By exploiting the ability of an organism to evolve in response to punishment from a hostile environment, scientists have coaxed the bacterium Escherichia coli to drastically resist ionizing radiation, and at the same time, reveal the genetic mechanisms that make the feat possible. More...


The study, published March 4, 2014, in the online journal eLife, provides evidence that only several genetic mutations give E. coli the capacity to tolerate doses of radiation that would otherwise kill the microbe. The findings are important because they have implications for better determination of how organisms can resist radiation damage to cells and repair damaged DNA. “What our work shows is that the repair systems can adapt and those adaptations contribute a lot to radiation resistance,” said University of Wisconsin-Madison (USA) biochemistry Prof. Michael Cox, the senior author of the report.

Prof. Cox and his group, working with John R. Battista, a professor of biological sciences at Louisiana State University (Baton Rouge, USA), in earlier research demonstrated that E. coli could evolve to resist ionizing radiation by exposing cultures of the bacterium to the highly radioactive isotope cobalt-60. “We blasted the cultures until 99% of the bacteria were dead. Then we’d grow up the survivors and blast them again. We did that 20 times,” explained Prof. Cox.

The outcome was E. coli capable of enduring as much as four orders of magnitude more ionizing radiation, making them similar to Deinococcus radiodurans, a bacterium that lives in the desert found in the 1950s to be incredibly resistant to radiation. That bacterium is capable of surviving more than one thousand times the radiation dose that would kill a human. “Deinococcus evolved mainly to survive desiccation, not radiation,” Prof. Cox said, “so when conditions are right, it can repair damage very quickly and start growing again.”

Determining the molecular machinery that allows some organisms to survive what would otherwise be deadly doses of radiation is significant because the same bacterial processes that repairs DNA and protects cells in microbes exists in humans and other organisms. Although turning the new findings into application is in the distant future, the new findings could eventually contribute engineered microbes capable of helping clean radioactive waste sites or making probiotics that could aid patients undergoing radiation therapy for some cancers.

The new study showed that organisms can actively repair genetic damage from ionizing radiation. Before this new research, scientists believed the ability of cells to resist radiation originated mostly from their ability to detoxify the reactive oxygen molecules created by radiation within cells.

That passive detoxification approach, noted Dr. Cox, is in all probability working in tandem with active processes such as the mutations found by these investigators as well as other, yet-to-be-discovered mechanisms. “This extreme resistance we’re looking at is a complicated phenotype,” said Dr. Cox. “There are likely additional mechanisms buried in this data and we're working to pull those out.”

Related Links:

University of Wisconsin-Madison



Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Electrolyte Analyzer
CBS-4000 (CBS-400)
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Research team leader Professor Klaus Gerwert and study lead author Dr. Grischa Gerwert in a betaSENSE laboratory (Photo courtesy of Dennis Yenmez/Stadt Bochum)

Blood-Based Sensor Detects Early Signs of Alzheimer’s and Parkinson’s

Alzheimer’s disease and Parkinson’s disease are increasing as populations age, yet diagnosis remains largely symptom-driven and often occurs after irreversible brain damage has begun. Earlier detection,... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.